Bob DeMarco Alzheimer's Reading Room

Tuesday, June 17, 2008

Study Shows Alzheimer's Drug Bapineuzumab effective in some patients


clipped from online.wsj.com
Pharmaceutical partners Wyeth and Elan Corp. said Tuesday results from a highly anticipated midstage study of their experimental Alzheimer's disease drug bapineuzumab show the treatment appears to be effective in some patients.

Bapineuzumab didn't show a statistically significant difference compared with placebo in all patients, but the companies said it suggested a trend toward improving cognitive function.

Bapineuzumab is designed to work by attacking a substance in the brain called beta-amyloid. There is a growing scientific consensus that a buildup of beta-amyloid is responsible for Alzheimer's.

blog it